Further evidence for a human B cell activating factor distinct from IL-4

Area of Science:

• Immunology
• Cell Biology

Background:

• Activated T cell supernatants contain B cell-activating factor (BCAF) that stimulates resting B cells.
• Human interleukin-4 (IL-4) also acts on resting B cells, necessitating a distinction between these factors.

Purpose of the Study:

• To investigate the relationship between BCAF and IL-4 in human B cell activation.
• To determine if BCAF and IL-4 are distinct entities triggering different B cell activation pathways.

Main Methods:

• Comparing the effects of T cell clone supernatants with and without detectable IL-4 on B cell proliferation and CD23 expression.
• Assessing B cell activation markers, including HLA-DR, -DP, -DQ antigen expression, and cell cycle progression (G1 phase, mitosis).

Main Results:

• Supernatants containing BCAF, but not IL-4, induced B cell proliferation without increasing CD23 expression.
• IL-4 induced CD23 expression on B cells, but did not drive proliferation in the absence of BCAF.
• T cell supernatants increased HLA antigen expression and promoted B cell entry into the cell cycle and mitosis, independent of IL-4, IFN-gamma, or LT.

Conclusions:

• BCAF and IL-4 are distinct activities that activate human B cells through different pathways.
• A B cell-activating factor (BCAF) is confirmed to be responsible for the activation of resting human B cells.